Firms unite to develop drugs targeting protein homeostasis

Forma Therapeutics and Celgene will collaborate in the discovery, development and commercialization of drug candidates that can regulate protein homeostasis targets. Forma will get an upfront payment and as much as $200 million in research funding. In exchange, Celgene will get the rights to develop and market several drug candidates outside the U.S. Forma will keep the U.S. rights to the drugs arising from the collaboration.

View Full Article in:

Genetic Engineering & Biotechnology News · BioWorld (free content)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC